Research / TPTS / Fundamental state Inspectable configuration
State dimensions Filing 0001674356-24-000033 Reit
Debt 44th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.gross_debt
$312.9M · CORE · VALID
Revenue growth 7th Own-history percentile · N=14
Evidence method Yoy · gp.fundamentals.revenue
-28.66% · CORE · VALID
Cash and equivalents 39th Own-history percentile · N=18
Evidence method Level · gp.fundamentals.cash
$21.2M · CORE · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 22 states Self-history eligible
Sep 30, 2021 0/6 normalized Level 3 Dec 31, 2021 0/6 normalized Level 3 Mar 31, 2022 2/5 normalized Level 3 Jun 30, 2022 2/5 normalized Level 3 Sep 30, 2022 2/4 normalized Level 3 Dec 31, 2022 2/5 normalized Level 3 Mar 31, 2023 4/5 normalized Level 3 Jun 30, 2023 4/6 normalized Level 3 Sep 30, 2023 3/3 normalized Level 3 Dec 31, 2023 5/5 normalized Level 3 Mar 31, 2024 5/6 normalized Level 3 Jun 30, 2024 4/4 normalized Level 3 Sep 30, 2024 3/3 normalized Level 3 Dec 31, 2024 4/4 normalized Level 3 Mar 31, 2025 4/4 normalized Level 3 Jun 30, 2025 4/4 normalized Level 3 Sep 30, 2025 5/5 normalized Level 3 Dec 31, 2025 4/4 normalized Level 3 Mar 31, 2026 5/5 normalized Level 3 Jun 30, 2026 4/4 normalized Level 4 Period transition
What moved in the state? Debt Decreased
Previous $383.8M
Current $312.9M
Delta -$70.9M Growth Increased
Previous -40.51%
Current -28.66%
Delta 11.85% Liquidity Increased
Previous $18.9M
Current $21.2M
Delta $2.3M Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.